Dark Forest Capital Management LP Aurinia Pharmaceuticals Inc. Transaction History

Dark Forest Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$7.77 - $12.27 $535,757 - $846,041	68,952 Added 149.03%	115,220 $895,000
Q2 2023 Aug 14, 2023	BUY	$8.96 - $11.69 $352,280 - $459,615	39,317 Added 565.63%	46,268 $447,000
Q1 2023 May 12, 2023	BUY	$5.94 - $11.27 $39,512 - $74,968	6,652 Added 2224.75%	6,951 $76,000
Q4 2022 Feb 13, 2023	BUY	$4.11 - $8.14 $1,228 - $2,433	299 New	299 $1,000
Q2 2022 Aug 15, 2022	SELL	$8.95 - $12.8 $33,499 - $47,910	-3,743 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$10.05 - $22.48 $27,707 - $61,977	2,757 Added 279.61%	3,743 $46,000
Q4 2021 Feb 11, 2022	BUY	$17.78 - $33.08 $17,531 - $32,616	986 New	986 $23,000

208

58.1M

1.14M

1.51M

Ticker AUPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,892,000
Market Cap $1.14B
Description
Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...

Get notified when there are updates to the investment portfolio of Dark Forest Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Dark Forest Capital Management LP with notifications on news.